[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100511314":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":27,"centralContacts":31,"locations":40,"responsibleParty":154,"collaborators":10,"id":156,"slug":157,"hasResults":158,"nctId":159,"briefTitle":160,"officialTitle":161,"acronym":162,"eligibilityCriteria":163,"healthyVolunteers":158,"sex":164,"minAge":10,"maxAge":165,"enrollmentInfo":166,"targetDuration":169,"studyType":170,"phases":10,"briefSummary":171,"conditions":172,"keywords":10,"overallStatus":43,"whyStopped":10,"lastUpdateSubmitDate":176,"lastUpdatePostDateStruct":177,"startDateStruct":180,"completionDateStruct":182,"leadSponsor":184,"locationsCount":185},{"fullName":5,"class":6},"University Hospital, Bordeaux","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Immune thrombocytopenia (ITP)",null,"Immune thrombocytopenia (ITP) : defined according to the international working group criteria (Rodeghiero et al., Blood 2009).",[13],"Other: data collection",{"label":15,"type":10,"description":16,"interventionNames":17},"Autoimmune Hemolytic anemia (AIHA)","Autoimmune haemolytic anaemia (AIHA) : Hb \\\u003C 110 g\u002FL with a positive direct antiglobulin test (DAT) and at least one of the following haemolysis criteria: reticulocyte count \\> 120 G\u002FL, free bilirubin \\> 17 mmol\u002FL, or haptoglobin \\\u003C 10 mg\u002FdL.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Evans syndrome (all bi or tri cytopenias)","Evans syndrome (ES) : simultaneous (less than 1 month) or sequential association of at least two autoimmune cytopenia among ITP, AIHA and autoimmune neutropenia (AIN).",[13],[23],{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":10},"data collection","description of the long-term health of adult patients, identification of the heterogenous genetic underlying pathophysiologic contexts, study of the benefit-risk balance of treatments, including the growing development of targeted therapies.",[15,19,9],[28],{"name":29,"affiliation":5,"role":30},"Nathalie ALADJIDI, MD","PRINCIPAL_INVESTIGATOR",[32,36],{"name":29,"role":33,"phone":34,"phoneExt":10,"email":35},"CONTACT","+33 557820261","nathalie.aladjidi@chu-bordeaux.fr",{"name":37,"role":33,"phone":38,"phoneExt":10,"email":39},"Aurore Capelli","0557820877","aurore.capelli@chu-bordeaux.fr",[41,57,70,83,94,106,118,130,142],{"facility":42,"status":43,"city":44,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"CHU Amiens Picardie Service d' Onco-Immuno-Hématologie Pédiatrique","RECRUITING","Amiens","France","FR",{"type":48,"coordinates":49},"Point",[50,51],2.3,49.9,{"lat":51,"lon":50},[54],{"name":55,"role":33,"phone":10,"phoneExt":10,"email":56},"Valérie LI THIAO TE","lithiaote.valerie@chu-amiens.fr",{"facility":58,"status":43,"city":59,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":60,"geoPoint":64,"contacts":65},"CHU d'Angers Unité d'Hémato-Oncologie Pédiatrique","Angers",{"type":48,"coordinates":61},[62,63],-0.55202,47.47156,{"lat":63,"lon":62},[66,68],{"name":67,"role":33,"phone":10,"phoneExt":10,"email":10},"Isabelle PELLIER",{"name":69,"role":33,"phone":10,"phoneExt":10,"email":10},"ispellier@chu-angers.fr",{"facility":71,"status":43,"city":72,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"BESANCON CHU de Besançon Hôpital Jean MINJOZ Unité d'Hémato-Oncologie Pédiatrique, Pédiatrie 1","Besançon",{"type":48,"coordinates":74},[75,76],6.01815,47.24878,{"lat":76,"lon":75},[79,81],{"name":80,"role":33,"phone":10,"phoneExt":10,"email":10},"Nathalie CHEIKH",{"name":82,"role":33,"phone":10,"phoneExt":10,"email":10},"ncheikh@chu-besancon.fr",{"facility":84,"status":43,"city":85,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"CHU de Bordeaux - Unité d'Hématologie et d'Oncologie pédiatrique","Bordeaux",{"type":48,"coordinates":87},[88,89],-0.58046,44.84124,{"lat":89,"lon":88},[92],{"name":93,"role":33,"phone":10,"phoneExt":10,"email":35},"Nathalie ALADJIDI",{"facility":95,"status":43,"city":96,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"CHU BREST Hôpital Morvan Unité d'Onco-Hématologie","Brest",{"type":48,"coordinates":98},[99,100],-4.48628,48.39029,{"lat":100,"lon":99},[103],{"name":104,"role":33,"phone":10,"phoneExt":10,"email":105},"LIANA CARAUSU","liana.carausu@chu-brest.fr",{"facility":107,"status":43,"city":108,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"CHU de Caen Unité d'Onco-Hématologie","Caen",{"type":48,"coordinates":110},[111,112],-0.35912,49.18585,{"lat":112,"lon":111},[115],{"name":116,"role":33,"phone":10,"phoneExt":10,"email":117},"Marianna DEPARIS","deparis-m@chu-caen.fr",{"facility":119,"status":43,"city":120,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"CHU de Clermont Ferrand","Clermont-Ferrand",{"type":48,"coordinates":122},[123,124],3.08682,45.77969,{"lat":124,"lon":123},[127],{"name":128,"role":33,"phone":10,"phoneExt":10,"email":129},"Eric DORE","edore@chu-clermontferrand.fr",{"facility":131,"status":43,"city":132,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"APHP Hôpital Bicêtre Service de Pédiatrie générale","Paris",{"type":48,"coordinates":134},[135,136],2.3488,48.85341,{"lat":136,"lon":135},[139],{"name":140,"role":33,"phone":10,"phoneExt":10,"email":141},"Corinne GUITTON","corinne.guitton@aphp.fr",{"facility":143,"status":43,"city":144,"state":10,"zip":10,"country":45,"countryCode":46,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"CH de Cornouaille Service de Pédiatrie","Quimper",{"type":48,"coordinates":146},[147,148],-4.09795,47.99597,{"lat":148,"lon":147},[151],{"name":152,"role":33,"phone":10,"phoneExt":10,"email":153},"Philippe VIC","p.vic@ch-cornouaille.fr",{"type":155,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100511314","obscerevance-french-cohort-of-pediatric-autoimmune-cytopenia-100511314",false,"NCT05937828","OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia","\"French National Cohort of Patients With Pediatric-onset of Autoimmune Cytopenia (OBS'CEREVANCE Cohort)\"","OBS'CEREVANCE","Inclusion Criteria:\n\n* Diagnosis of ITP, AIHA, Evans Syndrome\n* Onset before the age of 18\n\nExclusion Criteria:\n\n* Opposition of legal representative or to data collection","ALL","17 Years",{"count":167,"type":168},3500,"ESTIMATED","19 Years","OBSERVATIONAL","From 2004, OBS'CEREVANCE is a national real-world prospective clinical cohort of patients with auto-immune cytopenia of pediatric-onset : Immune thrombocytopenia (ITP), Autoimmune Hemolytic anemia (AIHA), or Evans syndrome (all bi or tri cytopenias). Thanks to the collaboration of the 30 French pediatric hematologic centers, this cohort supports all of the Rare Disease Centre CEREVANCE (Centre de Référence National des Cytopénies Auto-Immunes de l'Enfant) missions for care, education and research. Specifically, this original unbiased database allows to describe the long-term health of adult patients, to identify the heterogenous genetic underlying pathophysiologic contexts, and to study the benefit-risk balance of treatments, including the growing development of targeted therapies.",[173,174,175],"Immune Thrombocytopenia","Autoimmune Hemolytic Anemia","Evans Syndrome","2023-07-07",{"date":178,"type":179},"2023-07-10","ACTUAL",{"date":181,"type":179},"2010-09-01",{"date":183,"type":168},"2029-12-31",{"name":5,"class":6},9]